Thank you very much for the submission of your research manuscript to our editorial office. We have now received the full set of reviews on your manuscript.
Thank you very much for the submission of your research manuscript to our editorial office. We have now received the full set of reviews on your manuscript.
As the detailed reports are pasted below I will only repeat the main points here. You will see that the reviewers appreciate the interest of your findings and are, in principle, supportive of publication of your study in our journal. However, they also point out aspects of your study that would need to be further strengthened before publication and while this is most obvious in the report of referee 1 -for whose sometimes harsh tone I would like to apologize -both referees 2 and 3 agreed on the main concerns raised by this reviewer when they were asked to comment on each others' reports. For example, all reviewers agree that the FRAP experiments should be strengthened by using an additional FA marker. They also feel that the fragmented Golgi morphology should be analyzed or explained better and that the quality of the western blot of active FAK should be improved with more equal protein loading. With regard to the microarray data, this should be presented in a clearer way and the discrepancies between this dataset and the qPCR data should be explained. Furthermore, the levels of IL-24 protein in the different conditions/cells should be analyzed and shown. Finally, both referees 2 and 3 state that in several cases rescue experiments are needed to strengthen the conclusions. With regard to additional mechanistic insight into the link between RhoA and IL-24, we consider this to be beyond the scope of the current manuscript and would not make this a prerequisite for publication.
Given these the overall interest of your findings and the reviewers constructive comments on how to improve the study, I would like to give you the opportunity to revise your manuscript, with the understanding that the main concerns of the reviewers should be addressed. Acceptance of the manuscript will depend on a positive outcome of a second round of review and I should also remind you that it is EMBO reports policy to allow a single round of revision only and that therefore, acceptance or rejection of the manuscript will depend on the completeness of your responses included in the next, final version of the manuscript.
Revised manuscripts should be submitted within three months of a request for revision; they will otherwise be treated as new submissions. If you feel that this period is insufficient for a successful submission of your revised manuscript I can potentially extend this period slightly. Also, the length of the revised manuscript should not exceed roughly 28,000 characters (including spaces and references). If you feel that the additional data requested by the reviewers would make the manuscript too long you may consider including some peripheral data in the form of Supplementary information. However, Materials and Methods essential for the repetition of the main experiments should not be displayed as supplementary information only.
As part of the EMBO publication's Transparent Editorial Process, EMBO reports publishes online a Review Process File to accompany accepted manuscripts. This File will be published in conjunction with your paper and will include the referee reports, your point-by-point response and all pertinent correspondence relating to the manuscript.
You are able to opt out of this by letting the editorial office know (emboreports@embo.org). If you do opt out, the Review Process File link will point to the following statement: "No Review Process File is available with this article, as the authors have chosen not to make the review process public in this case."
We also welcome the submission of cover suggestions or motifs that might be used by our Graphics Illustrator in designing a cover.
I look forward to seeing a revised form of your manuscript when it is ready. Should you in the meantime have any questions, please do not hesitate to contact me.
REFEREE REPORTS:
Referee #1:
This manuscript reports on the role of p120catenin in controlling RhoA and IL-24 secretion that the authors propose acts to regulate keratinocyte migration through two different pathways. p120-dependent regulation of the RhoA pathway has previously been published by other groups, and the mechanism is relatively well understood, but the potential for controlling dual pathways in different migration modes is potentially novel and interesting. However, the current manuscript falls short of providing convincing evidence that these proposed pathways exist at present. Most of the data is either unconvincing or apparently contradictory and these discrepancies make interpretation difficult, and make it hard to reach any firm conclusions. The author's conclusions are thus overstated and poorly supported. Specific issues and concerns are as follows: -Fig1: the authors make some interesting observations here but these are not discussed, followed up or validated in any other model system. Thus there are many unanswered questions -why do integrin levels change in p120-/-cells (although this was not validated by western blotting or FACS analysis -or active integrins analysed so the evidence is weak) and result in increased adhesion? It is also not clear why zyxin was chosen for the FRAP experiment, or whether zyxin localization or expression in changed in p120-/-cells. Moreover, the FRAP t1/2 data appears to have been calculated incorrectly from the fluorescence recovery curves shown. The half-life should be taken as the time at which 50% of the fluorescence levels are recovered in cells -in WT cells this appears to be ~35seconds -in p120-/-cells it appears to be ~40seconds -it is not clear how the authors reach the 55seconds shown in 1D. The movies also show a very good recovery of signal in p120-/-cells so the reason for the extremely low recovery shown in 1C is also not clear. If the authors are to conclude anything regarding FA turnover, this should be formally measured over longer time courses to determine the assembly/disassembly rates of FA, using another FA marker such as vinculin or paxillin.
-The migration plots in 1E and 1H are chaotic -is this one cell per genotype or more than one? Start and end points must be marked. If the x/y values are correct it seems these cells do not migrate at all -0.2um is less than 1/100th of a cell length, and migration distances of 1.5um in 1F would barely register when analyzing these cells. Notably the use of nm/sec to plot migration speed data in 1F and 1I is impossible -0.01nm is not resolvable even using super-resolution microscopy -so how can the authors propose to measure migration over such a vanishingly small distance using a low magnification objective lens? -Why do WT cells not close the wounds in 1H? This is a real concern -and the movies appear to show the WT cells are even moving backwards in this assay. This seems to be a technical problem with the assay as normal mouse keratinocytes have been extensively published before to behave highly reproducibly and migrate rapidly into the wound space over short (<6h, the authors here measure over 12h) time periods. It would appear the authors have likely removed the ECM proteins in the wound area that are fundamentally required for cell migration in this assay, and potentially due to differences in wounding technique, this was not the case in the p120-/-cell preparations. These issues combined result in considerably low confidence in the data presented in Figure1, S1 and Figure 2 (which uses the same assays, and has the same issues) and thus any conclusions drawn from these datasets by the authors, and the premise for the subsequent experimental analysis, are highly questionable.
-The Golgi staining in FigS1J is very bizarre -the Golgi appears to be highly fragmented in p120-/-cells, and distributed round the entire cell as opposed to normal staining in control cells. There is no clear polarity of either cell type to the wound in the images. This is not commented upon by the authors, and in fact does not relate to the rest of the paper, so it would be best removed if the strange staining pattern cannot be explained. -The authors report no differences in active FAK between cell types but the blots in S1I show clear differences -higher at 0 in -/-cells and lower at 8h. It is not clear how the authors reached their conclusions from this data.
-The authors state their analysis in Fig2 is cell autonomous -this is made obvious by the fact they are using identical genotypes of cells in isolation, as is the case for any cell culture experiments, and use of this term here is inappropriate. Indeed, this term is mis-used regularly by the authors during the manuscript and should be removed to avoid mis-leading interpretation.
-The authors then jump to microarray analysis in Fig3, which is confusingly presented -3A shows a single set of specifically chosen hits -it is not clear if these represent increases/decreases in WT vs p120-/-or vice versa. Either way, the data in 3A shows TNFalpha levels are reduced and IL24 levels unchanged -whereas data in 3B shows they are both instead increased in p120-/-cells. This calls into question whether any data in the microarray can be trusted at all. Moreover, the authors never show at any point that protein or release of IL-24 is changed in p120-/-ells -this would be essential.
-Why was mouse IL-24 subsequently overexpressed in both cell types? Again, no evidence that IL-24 protein production was increased in these cells is provided, meaning interpretation of subsequent migration analysis (which in itself is already highly questionable, see above concerns) is unclear. The RhoA data (again, the reasoning behind this set of experiments is not made clear) in Fig4 is again not backed up by analysis of secretion of IL24, nor is any mechanistic link offered between the RhoA and Il24 pathways. Considerably more elegant and convincing analysis of p120-dependent changes in inflammatory signaling networks has been published by the senior author on this paper in 2006. The current data unfortunately falls very short of this previous work and offers no novel additional insight into this process.
Referee #2:
The authors elegantly show that loss of p120 in keratinocytes induces migration and wound healing via intrinsic and extrinsic signaling pathways regulated by Rho-dependent mechanisms. The authors make use of an previous published model in which they showed that loss of p120 in the epidermis leads to hyperplasia and inflammation. Loss of p120 has been linked to a migrational phenotype and secretion of pro-inflammatory cytokines in a number of different tumor models before and the data described by the authors in this manuscript confirms to this notion. However, while the authors show that Rho activity is pivotal in the regulation of IL24 transcription, no direct mechanism is provided that could explain the increase in IL24 levels upon loss of p120. In addition, the regulative role for p120 in this process remains cloudy. Nonetheless, the paper will be interesting to researchers working in the field of adhesion. The paper is well-written and will ultimately be suitable for publication in EMBO Reports. After carefully reading the manuscript some concerns were raised which are listed below:
Major concerns:
1. The authors claim in Figure 3F /G/H that knockdown of IL24 in p120 null keratinocytes abolishes the increased migration of these cells. However, to rule out any secondary effects of the used hairpin the authors should attempt to rescue the phenotype by introducing a non-targetable cDNA for IL24 or use a second independent hairpin against IL24. Figure 4H /I, the authors show that introduction of wildtype and ΔE-cad p120 (but not ΔRRD p120) can severely decrease IL24 transcription in p120 null cells. In Figure 4H they show that these p120 constructs are overexpressed between 75 and 250 fold judged by qPCR. Overexpression of p120 will severely alter the morphology of the cells due its Rho modulating capabilities. To rule out the possibility that the observed reduced IL24 mRNA levels are due to the extreme disruption of the cytoskeleton due to p120-mediated Rho inhibition, the authors should attempt to rescue the p120 null cells with physiologically relevant levels of the different p120 constructs to confirm their findings and substantiate the role of p120 in this process. In addition, it would be interesting to see if the p120 addback could rescue the migration phenotype and morphology in p120 null cells.
In
3. The authors elegantly show in a number of ways that RhoA inhibition leads to a decrease in IL24 transcription. However, how IL24 transcription is directly or indirectly regulated by RhoA remains elusive. Have the authors performed a promoter analysis on the IL24 promoter region? IL24 has been implicated as Ras/MAPK target in literature. One possibility would be that loss of p120 leads to growth factor sensitization and subsequent downstream signaling as was recently shown in a breast cancer model. The authors should discuss possible mechanisms and recent literature in this section.
Minor concerns:
1. In Figure 2F the error bars and the p-values are lacking which makes interpretation of the graph challenging due to the marginal differences between conditions. 2. In the text the authors refer to Figure 4C for the dominant-active RhoA experiment. This should be Figure 4D. 3. In Figure 4F two bars are shown which are not described in the graph legend. The legend should be adjusted. 4 . Throughout the paper microscopy data is quantified and presented in boxplots and bar graphs (e.g. S1B/C/D etc.). It would be helpful for interpretation of this data if the authors would state the number of cells that were analyzed.
5. Figure S1I shows a clear decrease in pFAK levels in p120 null cells in a scratch assay while they state in the text that 'No differences in the total levels of paxillin, vinculin, and pFAK were observed by immunoblot'. The text referring to Figure S1I should be considered for revision.
Referee #3:
Epifano and co-workers have analyzed the role of p120 catenin in keratinocyte migration. They demonstrate that loss of p120 leads to opposite effects in individual and collective migration.
Whereas single cell migration is significantly reduced, possibly due to reduced turnover of focal adhesions, collective migration is significantly enhanced. The authors investigate this further and find enhanced expression of IL24. IL 24 is found to enhance migration of wildtype cells and to be transcriptionally regulated through a pathway involving RhoA.
The authors do a nice job in analyzing the migratory phenotypes of the p120 knockout cells. In particular, the analyses of the collective cell migration and the role of IL 24 are convincing and well executed. The only major shortcoming of the manuscript is the lack of mechanistic correlation between the 2 modes of migration. Since the enhancement of collective migration by loss of p120 seems to be independent of cell-cell contacts, as it is found to be present in the absence of calcium, one would expect that the phenotypes of reduced focal adhesion turnover and increased integrin expression would be still present on confluent plates. Therefore the switch from reduced to enhanced migration seems rather striking and it should be addressed in more detail whether this can be solely attributed to IL24.
Specific points: 1) Can application of IL24 or condition medium from confluent p120 delta/delta cells rescue the single cell migration defect? This should be assessed.
2) The authors nicely show that expression of wt p120 or E-cad binding mutant can rescue IL24 expression. It would be important to show that wt p120 can also rescue the two different migration defects.
3) The authors should assess whether the collective cell migration phenotype is indeed independent of cell-adhesion by performing a rescue experiment with the E-cad binding mutant. Response to the reviewers' comments Referee #1
Fig1: the authors make some interesting observations here but these are not discussed, followed up or validated in any other model system. Thus there are many unanswered questions -why do integrin levels change in p120-/-cells (although this was not validated by western blotting or FACS analysis -or active integrins analyzed so the evidence is weak) and result in increased adhesion?
We now show the integrin composition and their levels at the membrane using FACS analysis (FigS1C). The activation of integrin signaling was measured by analyzing the downstream integrinsignaling effectors pFAK and pPaxillin.
Although beyond the present study, the detailed mechanistic analysis of FA turnover defect is most likely rooted in microtubule disorganization upon loss of p120 [1, 2] .
The change in the integrin composition upon reductions in AJs has been previously documented, supporting the concept of the existence of an adhesive crosstalk between AJs and FAs [3] [4] [5] . Zyxin was chosen since it is a gold standard protein to study FA dynamics in different cell types [6] [7] [8] . As the movies show, in absence of p120 the localization of zyxin is still maintained in the FAs and also the amount of protein expressed after transfection in control and p120 null cells was similar.
It is also not clear why zyxin was chosen for the FRAP experiment, or whether zyxin localization or expression is changed in p120-/-cells. Moreover, the FRAP t1/2 data appears to have been calculated incorrectly from the fluorescence recovery curves shown. The half-life should be taken as the time at which 50% of the fluorescence levels are recovered in cells -in WT cells this appears to be ~35seconds -in p120-/-cells it appears to be ~40seconds -it is not clear how the authors reach the 55seconds shown in 1D. The movies also show a very good recovery of signal in p120-/-cells so the reason for the extremely low recovery shown in 1C is
Regarding the calculation of the half-life (t 1/2 ), the normalized FRAP data was fitted to the following one-phase exponential equation:
The fitted coefficients were used for calculating the half-life of the FRAP curve as follow:
The values represented in the The fitted data shows a nice correlation with the experimental data. The half-life values calculated by graphical interpolation are 31s for p120 L/L and 44s for p120Δ/Δ, showing a similar difference between both but with lower values. Both ways reflect the same trend.
As the referee nicely suggested, we now include the FRAP analysis of vinculin, other FA protein (new supplementary Fig1SF). The obtained results are similar to those obtained with zyxin, although vinculin presented a more diffusive behavior. We performed our FRAP analysis until the protein reaches the plateau of fluorescence recovery; therefore, longer time periods of analyses were not necessary. Based upon these findings, we conclude that in absence of p120, there is a reduction in the fluorescence recovery after photobleaching in absence of p120, indicating a reduction of FA dynamics and turnover. We agree with this referee and modified all the figures accordingly to show the values expressed in µm/h. We also corrected the values of individual cell migration.
The migration plots in 1E and
The migration plots were also modified to indicate that the initial time point is 0, and the end time points were marked with a symbol. In addition, all figure legends indicate the number of experiments and the number of cell tracks analyzed. A representative cell track per genotype is shown in our migration plots. In general, normal mouse keratinocytes heal wounds in ∼12 h in both low and normal calcium conditions [9-11]. Based on our findings and other published observations, the reviewer is right that WT cells under low calcium conditions are more dynamic, and move back and forth during wound healing since they are not establishing cell-cell contacts.
Why do WT cells not close the wounds in 1H? This is a real concern -and the movies appear to
To rule out if the wounding technique affected our results by perturbing the ECM coating, we used Oris Cell Migration Assay with plates coated with Fibronectin. This system uses cell stoppers that when removed do not perturb the coating matrix. Our new results confirmed our in vitro scratch wound healing findings indicating that p120Δ/Δ mKer migrate faster than p120 L/L control mKer. See new supplementary Fig S2C. 
5.The Golgi staining in FigS1J is very bizarre -the Golgi appears to be highly fragmented in p120-/-cells, and distributed round the entire cell as opposed to normal staining in control cells. There is no clear polarity of either cell type to the wound in the images. This is not commented upon by the authors, and in fact does not relate to the rest of the paper, so it would be best removed if the strange staining pattern cannot be explained.
We agree with the reviewer that these findings do not relate with the rest of the paper, and these data were removed from the manuscript.
The authors report no differences in active FAK between cell types but the blots in S1I show clear differences -higher at 0 in -/-cells and lower at 8h. It is not clear how the authors reached their conclusions from this data.
We repeated the experiment to confirm these results and modified the text accordingly. A clear increase in pFAK at time=0 was observed in p120 null cells, although at 8 hours no differences were detected compared to controls. New supplementary Fig S1J. 
The authors state their analysis in Fig2 is cell autonomous -this is made obvious by the fact they are using identical genotypes of cells in isolation, as is the case for any cell culture experiments, and use of this term here is inappropriate. Indeed, this term is mis-used regularly by the authors during the manuscript and should be removed to avoid mis-leading interpretation.
We have removed the redundancies in the text. We initially used this term because the ablation of the protein was made in vitro, and allow us to study the behavior of the cells in a cell autonomous manner. We have now modified the figures and the text to show our data in a clearer way. a. Fig 3A represents the microarray results obtained using total mouse skin samples and the values were normalized relative to those in control mice. b. Fig 3B shows the RTPCR mRNA expression results obtained in cultured mKer in which the ablation was performed in vitro. This allowed us to analyze the factors that are produced by mKer instead of all the skin microenvironment. c. The chemokines and cytokines analyzed in vitro were selected from the data obtained in the total skin microarray based on the previously documented roles in cell migration.
The authors then jump to microarray analysis in
9. Moreover, the authors never show at any point that protein or release of IL-24 is changed in p120-/-ells -this would be essential.
We thank the reviewer for pointing out that the protein levels of IL24 would strengthen our data. We now include the IL24 protein expression levels in all the experiments that relate to this point throughout the paper. These include new figures for, 1) the expression of IL24 in both cell types (Fig 3C), 2 ) the experiments in which control mKer overexpress IL24 (Fig 3D), 3 ) the levels of IL24 in both cell types upon IL24 knock-down (Fig 3G), 4 
Why was mouse IL-24 subsequently overexpressed in both cell types? Again, no evidence that IL-24 protein production was increased in these cells is provided, meaning interpretation of subsequent migration analysis (which in itself is already highly questionable, see above concerns) is unclear. The RhoA data (again, the reasoning behind this set of experiments is not made clear) in Fig4 is again not backed up by analysis of secretion of IL24, nor is any mechanistic link offered between the RhoA and Il24 pathways. Considerably more elegant and convincing analysis of p120-dependent changes in inflammatory signaling networks has been published by the senior author on this paper in 2006. The current data unfortunately falls very short of this previous work and offers no novel additional insight into this process.
We performed gain of function studies, by expressing IL24 only in control cells, as a useful tool to test if IL24 is sufficient to increase cell migration (Fig 3D-E) .
Although beyond of the scope of the present study, we agree with this reviewer that understanding how RhoA mediated signals activate the transcriptional expression of IL24 will provide further insights about the molecular mechanism underlying the observed phenotypes, and we would direct our future research into that direction.
Referee #2 Figure 3F/ We thank the reviewer for raising this important point. We now indicate in the text that the knockdown of IL24 was performed using a combination of two different shRNAs. We have also included a new supplementary Fig S3C,D in which we show the reduction of IL24 using the two individual shRNAs, in addition to the results obtained when they were combined. We also include the effect of these different knockdown approaches in the migratory phenotype of p120 null cells when compared with Scr controls in the new supplementary Fig S3E. 
The authors claim in

In Figure 4H/I, the authors show that introduction of wildtype and ΔE-cad p120 (but not ΔRRD p120) can severely decrease IL24 transcription in p120 null cells. In Figure 4H they show that these p120 constructs are overexpressed between 75 and 250 fold judged by qPCR. Overexpression of p120 will severely alter the morphology of the cells due its Rho modulating capabilities. To rule out EMBO reports -Peer Review Process File -EMBOR-2013-37868 © European Molecular Biology Organization the possibility that the observed reduced IL24 mRNA levels are due to the extreme disruption of the cytoskeleton due to p120-mediated Rho inhibition, the authors should attempt to rescue the p120 null cells with physiologically relevant levels of the different p120 constructs to confirm their findings and substantiate the role of p120 in this process. In addition, it would be interesting to see if the p120 addback could rescue the migration phenotype and morphology in p120 null cells.
We agree with the reviewer that these experiments should be performed mimicking the levels that are present in mKer under normal conditions. To this end, we infected the p120 null cells with the three different p120-GFP constructs. The GFP+ cells were FACS sorted and the p120 mRNA expression levels were analyzed by qPCR (Fig4I). Cells with similar levels of GFP expression were used to perform our experiments (Supplementary Fig S4A) . In the new Fig4, we show that the re-expression of p120FL and p120ΔEcad is able to reduce the mRNA and protein expression levels of IL24, whereas this was not observed after the re-expression of the p120 mutant lacking the Rho regulatory domain (Fig 4J,K) .
We also attempted to analyze the effect in cell migration and morphology, however, the fact that p120 re-expression also induces the modulation of other RhoGTPases, including Rac1[12], technically precluded the possibility to observe a rescue of the migratory properties of p120 null cells ( Supplementary Fig S4B) . Indeed, even cells transfected with p120-FL-GFP and p120ΔEcad-GFP exhibiting low levels of GFP expression, presented the previously documented branching phenotype, associated with increased membrane dynamics and the acquisition of migratory characteristics (Fig S4C) [12].
The authors elegantly show in a number of ways that RhoA inhibition leads to a decrease in IL24 transcription. However, how IL24 transcription is directly or indirectly regulated by RhoA remains elusive. Have the authors performed a promoter analysis on the IL24 promoter region? IL24 has been implicated as Ras/MAPK target in literature. One possibility would be that loss of p120 leads to growth factor sensitization and subsequent downstream signaling as was recently shown in a breast cancer model. The authors should discuss possible mechanisms and recent literature in this section.
Although beyond the scope of the present manuscript, we agree with this reviewer that this analysis would provide further insights into the molecular mechanisms that regulate the transcription of IL24. We aim to direct our future studies into that direction. We have changed the manuscript and discuss now the possibility of a connection between our findings and those reported in the breast cancer model [13] . We have previously documented that loss of p120 also leads to an increase in MAPK [14] , and discussed the possible connection with our present findings in the migratory phenotype of p120 null cells.
In Figure 2F the error bars and the p-values are lacking which makes interpretation of the graph challenging due to the marginal differences between conditions.
We have included the missing error bars and the p-values in Figure 2F . Figure 4C for the dominant-active RhoA experiment. This should be Figure 4D .
In the text the authors refer to
We corrected this mistake and revised that all figures are properly mentioned in the text. Figure 4F two bars are shown which are not described in the graph legend. The legend should be adjusted.
In
We have now described these results in the figure legend and revised that all figures are properly mentioned in the text.
Throughout the paper microscopy data is quantified and presented in boxplots and bar graphs (e.g. S1B/C/D etc.). It would be helpful for interpretation of this data if the authors would state the number of cells that were analyzed.
We have added the information of the number of cells analyzed and the total n of performed experiments in the figure legends, and in the Material and Methods section of the manuscript. Figure S1I should be considered for revision.
Figure S1I shows a clear decrease in pFAK levels in p120 null cells in a scratch assay while they state in the text that 'No differences in the total levels of paxillin, vinculin, and pFAK were observed by immunoblot'. The text referring to
We thank this reviewer and reviewer 1 for making this point (See reviewer 1, point 6). We have repeated the experiment to validate our results and modified the text accordingly. It is now stated that pFAK levels are increased in p120 null cells at time=0, although at 8 hours no difference was detected between control and p120 null cells. We have included these data and modified the text accordingly.
Referee #3
Can application of IL24 or condition medium from confluent p120 delta/delta cells rescue the single cell migration defect? This should be assessed.
We thank the referee for this important point. We have included these data in the new supplementary Fig S2F showing that the IL24 conditioned medium can rescue the individual migratory defect of p120 null cells.
The authors nicely show that expression of wt p120 or E-cad binding mutant can rescue IL24 expression. It would be important to show that wt p120 can also rescue the two different migration defects. 3. The authors should assess whether the collective cell migration phenotype is indeed independent of cell-adhesion by performing a rescue experiment with the E-cad binding mutant.
We completely agree with this reviewer and the reviewer 2 that this information would substantiate our findings. See reviewer 2, point 2.
Although the re-expression of p120FL and p120ΔEcad, but not the re-expression of the p120 mutant lacking the Rho regulatory domain (Fig 4J,K) is able to reduce the mRNA and protein expression levels of IL24; the fact that re-expression of p120 also induces the modulation of other RhoGTPases, including Rac1[12], technically precluded the possibility to observe a rescue of the migratory properties of p120 null cells (Supplementary Fig S4B) . Even cells exhibiting low levels of GFP expression, presented the previously documented branching phenotype, associated with increased membrane dynamics and the acquisition of migratory characteristics (supplementary Fig S4C) [12].
Mislocalization is misspelled on p 4
This mistake is now corrected in the text. Supplementary Fig S3D that does not exist. Suppl. Fig S2D is probably correct.
There are some inconsistencies in figure numbering. For example on p6, first paragraph, there is a reference to
We corrected this mistake and revised that all figures are properly mentioned in the text. Many thanks for the submission of your revised study to EMBO reports. The manuscript was sent back to the three original referees and while they overall appreciate that the study has been strengthened during revision, both referee 3 and 1 still raise concerns that would need to be addressed before publication. For example, referee 3 raises the concern that re-introduction of p120 into the p120-deficient cells does not have seem to have an effect on cell migration and s/h suggests a potential way to address this. Along similar lines, referee 1 still does not feel that the data provides strong enough support for the claims made. For example, this reviewer states that the statistical significance (based on independent biological replicates) for all results and effects has to be demonstrated. Other concerns relate to missing controls (point 4) and inconsistencies between experiments that need to be explained (point 3). Point 1 relates to additional clarifications in the experimental design that would need to be provided.
Given the overall interest the referees expressed in your study, I would like to give you the exceptional opportunity to revise the study a second time, with the understanding that the concerns of referee 1 and 3 concerns have to be addressed before the study can be published in EMBO reports. Formally, papers in EMBO reports have to be accepted within 6 months of the initial decision, which in your case would be February 28, 2014. Given that the final version of the manuscript would still need to be evaluated by one or more of the reviewers, I would recommend a submission date for the final version around the beginning of February. Please also outline briefly in a point-by-point manner how you have addressed the remaining referee concerns.
Please do let me know if you anticipate problems with this time-frame, as I am sure we can find a solution.
REFEREE REPORTS:
The authors have revised the manuscript and included new data, some of which satisfactorily address previous comments from the last review round. However, there are a number of remaining issues that have not been addressed and currently make interpretation of some of the author's conclusions somewhat difficult. These are: -The authors have attempted to show a link between IL24 and RhoA. However, the data in fig 4 is currently very difficult to interpret. The C3 inhibitor used in 4A-C was evidently only applied to cells for 30 minutes. Were cells lysed immediately, and if so, how is it possible that mRNA and protein levels are so dramatically altered in such a short space of time (4A/B)? How soon after treatment with C3 were the conditioned media experiments performed, and were IL24 levels also monitored in parallel CM to determine levels in cells +/-C3? -The author's state they 'repeated' the western blots of active FAK and paxillin and have now concluded they are altered in activation status. This is extremely worrying -does this mean the data shown in the first version was result of only one experiment? The authors must provide evidence of multiple western blots and quantification if they are to include this data. Given they make no other attempt to link the observed focal adhesion/integrin level changes to anything else in the study, this data could provide a much-needed link.
-The lack of consistency between migration speeds for identical cell types throughout the manuscript is worrying. For example, the p120L/L migration speed/length in Fig 1I is almost twice that in Fig 2B ( this data is in the presence of L/LCM which one assumes should make no difference, although this is not discussed), yet a third slower than data in Fig 4C. If the experiments were performed multiple times in each case, how can these inconsistencies be explained? -Blots of lysates from cells expressing different p120 mutants must be shown in Fig4K to demonstrate equal protein expression levels. Why has the relative p120 mRNA level data changed shown in Fig 4I considerably Referee #2:
The authors have addressed the comments appropriately. We are happy with the comments and revisions made.
Referee #3:
The authors have addressed most of the points of the reviewers in a staistfactory manner and the manuscript has significantly improved. One significant concern however remains and that is that reintroduction of p120 into the p120-deficient cells does not at all influence the migration of these cells. It is perhaps not realistic to expect a complete rescue, due to the reasons the authors provide. However, the authors show nicely in Fig 4K that re-introduction of p120 into the p120-deficient cells completely rescues IL24 expression and in Fig 3H that depletion of IL24 rescues the migration defect. From this one can extrapolate that re-introduction of p120 into the p120-deficient cells should do something to the migration since IL24 should be gone, even if the cytoskeletal phenotype cannot be rescued due to the reasons provided by the authors.
Since it is of concern that the migration defect could be some sort of cell culture artifact, resulting for example of a compensatory effect of the p120-deficient cells in culture, the authors should make an attempt to address this. Since the re-expression of p120 obviously does not work, the second best approach would be to transiently deplete (not with shRNA but with siRNA to make a truly transient depletion) p120 in wt keratinocytes and analyze whether this produces a similar migration phenotype as seen in the p120 delta/delta cells. We have now clarified this aspect in the Material and Methods section. Cells were treated with the C3 inhibitor for 30 min. The inhibitor was then washed-out with PBS, followed by the addition of fresh cell culture medium. Cells or their conditioned media were harvested after 16 h, and used to perform the experimental analyses. It is important to mention that the C3 inhibitor irreversibly inhibits Rho GTPase by promoting its ADP-ribosylation. Although cells are still viable and neosynthesis of Rho can occur after days post treatment.
The results of the levels of IL24 expressed by cells treated with the C3 inhibitor are shown in Figure 4A . Regarding the levels of IL24 in the CM, technical limitations precluded those measurements by ELISA, since the serum concentration of the media (15%) precluded the optical concentration and analyses of the samples.
2) The author's state they 'repeated' the western blots of active FAK and paxillin and have now concluded they are altered in activation status. This is extremely worrying -does this mean the data shown in the first version was result of only one experiment? The authors must provide evidence of multiple western blots and quantification if they are to include this data. Given they make no other attempt to link the observed focal adhesion/integrin level changes to anything else in the study, this data could provide a much-needed link.
We wanted to express that we repeated the experiments to increase the n of the experiments shown in the previous version of the manuscript to provide the most representative data. We agree with this reviewer that statistical analyses and quantitative data are important in any experimental approach.
We have now included a graphical representation of our quantitative analyses. We are including the immunoblot scans of those experiments in this letter ( Figure 1 and Figure  2 ). We also include Tables showing the OD measurements of all immunoblots. The overall values of phospho-FAK are the ratio obtained between the total levels of pFAK relative to actin, divided by the total levels of FAK relative to actin. These results are represented as mean values ± SEM. of the pFAK:FAK ratios in the new Figure  S1J . The same approach was performed for p-Paxillin and Paxilin. In the case of Vinculin, the histogram represents the average of vinculin relative to actin.
3) We are glad to clarify these differences. Table 1 . These results represent the migratory behavior of mKer cells with fresh media. In other words, the media is replaced for fresh media before performing the experiments. Thus, migratory stimulator factors in the media are low and accumulate during the progression of the experiments. Table 2 . The rest of the experiments represent the migratory behavior of mKer cells (expressing normal levels of p120) exposed to the conditioned media of control or null cells. This conditioned media has accumulated factors secreted by cells after overnight incubations. We believe the differences are explained by the fact that CM posses an enrichment of soluble factors that affect cell migration. Overall, these treatments were always performed with a set of controls, n= 4 in triplicates. Normal variations exist in these biological approaches; however, the cellular effect is always consistent when similar treatments are compared. Fig. 4I . The difference between the levels shown in the first version of the manuscript and the second one is explained by the fact that we FACS-sorted the transfected cells and isolated the ones with similar levels of GFP expression to obtain comparable levels in each case, in addition to achieve a more physiological expression of all the constructs as suggested previously by Referee #2. Fig 3C is The referee is right about this oversight. We have now changed the immunoblot of the Fig. 3C using one of the additional experiments we have previously performed. We appreciate the suggestion of this reviewer. The levels of p120 need to be fine-tuned since it is well established that its overexpression leads to increases in cell migration. Thus, it has been technically difficult to perform rescue experiments in different cell systems, especially to determine the contribution of different p120 domains to cell behavior.
5) The IL24 western blot in
Following this suggestion, we transiently knocked-down p120 in control p120L/L mKer using a combination of 3 different siRNAs against p120 (Origene). Since primary mKer can only be maintained in culture for several days we perform these experiments from 0 h -96 h.
The results showed that mRNA levels are downregulated starting from 48 h ( Figure 3A ) which correlate with the observed reduction of p120 protein levels at 72 h ( Figure 3B ). However, at 96h, the levels of p120 recovered.
We also analyzed the expression of IL24, and observed a slight increase in its mRNA levels starting at 72 h, consistent with the reduction of p120. However, at 96 h these levels were reduced. We were not able to observe IL24 by immunoblot analyses most likely due to its reduced level of expression ( Figure 3C ).
Overall, these results support our previous data implicating p120 in the modulation of IL24.
We then turned to evaluate the effect in cell migration using the scratch wound healing in vitro approach, upon transitory downregulation of p120.
The histogram in panel D shows that during this small window of reduction of p120 (from 72-96 h), the primary effect is the reduction of cell migration, as observed in our individual p120 null cells, when IL24 is not accumulating in the media.
This is most likely due to the fact that IL24 proteins levels do not accumulate, compatible with the lack of its detection by immunoblot analyses. This is also explained by the fact that the decreases in p120 levels are only observed in a narrow window upon p120 knock down.
Globally, these data support the contribution of p120 in the modulation of cell migration. However, we were not able to observe the increase in cell migration due to the short time before p120 levels recovered. Therefore, we did not include this information in the manuscript. Answer to the reviewers comments. Figure 1 . Answer to the reviewers comments. Figure 2 . 
